Cleared Traditional

Stat Profile Prime Plus Analyzer System

K200204 · Nova Biomedical Corporation · Chemistry
Apr 2020
Decision
69d
Days
Class 2
Risk

About This 510(k) Submission

K200204 is an FDA 510(k) clearance for the Stat Profile Prime Plus Analyzer System, a Oxyhemoglobin (Class II — Special Controls, product code GGZ), submitted by Nova Biomedical Corporation (Walham, US). The FDA issued a Cleared decision on April 6, 2020, 69 days after receiving the submission on January 28, 2020. This device falls under the Chemistry review panel. Regulated under 21 CFR 864.7500.

Submission Details

510(k) Number K200204 FDA.gov
FDA Decision Cleared SESE
Date Received January 28, 2020
Decision Date April 06, 2020
Days to Decision 69 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Summary PDF

Device Classification

Product Code GGZ — Oxyhemoglobin
Device Class Class II — Special Controls
CFR Regulation 21 CFR 864.7500